
doi: 10.1038/nrc948
pmid: 12459732
Although the cytotoxic effects of viruses are usually viewed in terms of pathogenicity, it is possible to harness this activity for therapeutic purposes. Viral genomes are highly versatile, and can be modified to direct their cytotoxicity towards cancer cells. These viruses are known as oncolytic viruses. How are viruses engineered to become tumour specific, and can they be used to safely treat cancer in humans?
Clinical Trials as Topic, Cell- and Tissue-Based Therapy, Antineoplastic Agents, Virus Replication, Organ Specificity, Neoplasms, Viruses, Animals, Humans, Genetic Engineering, Virus Physiological Phenomena
Clinical Trials as Topic, Cell- and Tissue-Based Therapy, Antineoplastic Agents, Virus Replication, Organ Specificity, Neoplasms, Viruses, Animals, Humans, Genetic Engineering, Virus Physiological Phenomena
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 317 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 1% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 1% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 1% |
